EYE

0.00%

22.0¢ nova eye medical limited

Nova Eye Medical (EYE) Discussion, page-2353

First 2353 Last

Share
Profile

Follow
bar

645 Posts.

100

22/02/24

14:47

Post #: 72538645
Share

Originally posted by TheAnalyst007: ↑

Yeah I would say it is. It would be sort of pointless to establish a favourite stock with a long-term bias only to switch to a different stock as soon as there is a bit of pessimism in the market. Periods of short term pain and pessimism in markets are inevitable. The key in my view is being able to see the opportunity during these periods, rather than running away from it in fear, and backing your calls through the ups and downs. I remember immediately following the LCD news in late December, so many posters here were commenting about how they had wished they saw through the pessimism and loaded up at the lows. I wouldn't be surprised if the same happens again, a bit of pessimism that will immediately turn into optimism as soon as that big 2RT announcement arrives. A day later, like clockwork, everyone will be wishing they had bought at 21c lol.

Fundamentally, the company is doing really well. They have focused their limited resources on the US market and delivered strong performance in that market, with 65% growth despite the negative pressure of the LCD. Global wasn't fantastic, but they did clearly say they were going to focus on the US market. I don't think anyone should have expected much growth outside of the US. Now for the first time they have confirmed a near term date by which they will be cash flow positive, and with the recent CR they will be able to begin allocating more resources to the rest of the world. So fundamentally I would say things are very sound. On the cap raise front, no one likes dilution, but those funds are being entirely used to fund further growth, so it should be quite accretive in the longer term.

The market will be pessimistic for a bit longer I'm sure, but in my view the company is stronger than ever. So when you ignore the recent price action, I would say things have only really improved. The company is growing fast and now has a big pile of cash to play with. At only a $ 50m market cap, there is certainly plenty of upside here IMO.

Expand

The fact that there is a CR does that indicate that a 2RT announcement is 3 months or more off, i.e. directors buying or does that not apply when the offer is open to shareholders as well.

EYE Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

RCE

Recce's R327 found effective against E.coli during clinical trial

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

There are more pages in this discussion • 826 more messages in this thread...

First 2353 Last

Add EYE (ASX) to my watchlist

(20min delay)
Last 22.0¢		Change 0.000(0.00%)		Mkt cap ! $50.34M

Open	High	Low	Value	Volume
22.5¢	22.5¢	21.0¢	$95.62K	444.6K

Buyers (Bids)

No.	Vol.	Price($)
3	52740	21.5¢

Sellers (Offers)

Price($)	Vol.	No.
22.5¢	73205	2

View Market Depth

No.	Vol.	Price($)
3	52740	0.215
1	131378	0.210
4	91540	0.205
17	405320	0.200
1	3000	0.195

Price($)	Vol.	No.
0.225	73205	2
0.230	36950	3
0.235	100000	1
0.245	11000	1
0.250	49617	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

EYE (ASX) Chart

Nova Eye Medical (EYE) Discussion, page-2353

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Nova Eye Medical (EYE) Discussion, page-2353

Top Stories

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Recce's R327 found effective against E.coli during clinical trial

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News